CITALOPRAM HBR 20 MG TABLET
For 30 tablets
Pharmacies pay
$0.89 filed
30 × $0.0296 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$3.53 filed
30 × $0.11783 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
4.0× estimated
Medicare paid 4.0× what pharmacies pay.
Part D averages every strength and form sold under “Citalopram HBr” / “Citalopram Hydrobromide” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$6.02 estimated
$0.89 + $0.13 (15%) + $5.00 fee per fill = $6.02
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CITALOPRAM HBR 20 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “citalopram” and “citalopram hydrobromide”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Major Pharmaceuticals and Torrent Pharmaceuticals Limited.
FDA’s Established Pharmacologic Class for it is Serotonin Reuptake Inhibitor.
The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.89 for 30 tablets (30 × $0.0296 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 7 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Torrent Pharmaceuticals Limited | 3 | $0.0296 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.0296 per EA filed |
| Cipla USA Inc. | 2 | $0.0296 per EA filed |
| Exelan Pharmaceuticals Inc. | 2 | $0.0296 per EA filed |
| Mylan Pharmaceuticals Inc. | 2 | $0.0296 per EA filed |
| Major Pharmaceuticals | 1 | $0.0296 per EA filed |
| QUALLENT PHARMACEUTICALS HEALTH LLC | 1 | $0.0296 per EA filed |
All 13 NDCs, with labeler and price
- 00378-6232-01 · Mylan Pharmaceuticals Inc. · $0.0296 per EA · eff. 2026-09-23 filed
- 00378-6232-05 · Mylan Pharmaceuticals Inc. · $0.0296 per EA · eff. 2026-09-23 filed
- 00904-6085-61 · Major Pharmaceuticals · $0.0296 per EA · eff. 2026-09-23 filed
- 13668-0010-01 · Torrent Pharmaceuticals Limited · $0.0296 per EA · eff. 2026-09-23 filed
- 13668-0010-05 · Torrent Pharmaceuticals Limited · $0.0296 per EA · eff. 2026-09-23 filed
- 13668-0010-06 · Torrent Pharmaceuticals Limited · $0.0296 per EA · eff. 2026-09-23 filed
- 65862-0006-01 · Aurobindo Pharma Limited · $0.0296 per EA · eff. 2026-09-23 filed
- 65862-0006-05 · Aurobindo Pharma Limited · $0.0296 per EA · eff. 2026-09-23 filed
- 69097-0823-07 · Cipla USA Inc. · $0.0296 per EA · eff. 2026-09-23 filed
- 69097-0823-12 · Cipla USA Inc. · $0.0296 per EA · eff. 2026-09-23 filed
- 76282-0629-10 · Exelan Pharmaceuticals Inc. · $0.0296 per EA · eff. 2026-09-23 filed
- 76282-0629-90 · Exelan Pharmaceuticals Inc. · $0.0296 per EA · eff. 2026-09-23 filed
- 82009-0107-05 · QUALLENT PHARMACEUTICALS HEALTH LLC · $0.0296 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
6 other products in the NADAC file share an FDA nonproprietary name with CITALOPRAM HBR 20 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CELEXA 20 MG TABLET | $9.00923 per EA filed | $9.17789 per EA filed |
| CELEXA 40 MG TABLET | $9.469 per EA filed | $9.17789 per EA filed |
| CITALOPRAM HBR 10 MG TABLET | $0.02604 per EA filed | $0.11783 per EA filed |
| CITALOPRAM HBR 10 MG/5 ML SOLN | $0.17955 per ML filed | We don’t know yet |
| CITALOPRAM HBR 20 MG TABLET this page | $0.0296 per EA filed | $0.11783 per EA filed |
| CITALOPRAM HBR 30 MG CAPSULE | $4.76996 per EA filed | $0.11783 per EA filed |
| CITALOPRAM HBR 40 MG TABLET | $0.04136 per EA filed | $0.11783 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 13 NDCs’ NADAC prices is $0.0296 per EA filed.
Of the 58 other products in FDA’s Serotonin Reuptake Inhibitor class priced per EA, 55 have a higher middle NADAC price and 3 a lower one. The one in the middle is TRAZODONE 300 MG TABLET, at $0.49767 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $3.53 for 30 tablets, at an average of $0.11783 per EA in 2024 (2024-01-01 to 2024-12-31) for “Citalopram HBr” and “Citalopram Hydrobromide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 6,741,609 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CITALOPRAM HBR 20 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Citalopram HBr / Citalopram Hydrobromide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. 41 of 43 NADAC NDCs joined to this name are priced per EA (2 per ML): CMS's average mixes those units.
Related pages
Its pharmacologic class
Related in the same class
- TRAZODONE 100 MG TABLET
- SERTRALINE HCL 100 MG TABLET
- ESCITALOPRAM 10 MG TABLET
- FLUOXETINE HCL 10 MG TABLET
- PAROXETINE HCL 10 MG TABLET